Abstract |
The purpose of this study was to evaluate the safety and efficacy of laparoscopic splenectomy in patients with chronic lymphocytic leukemia (CLL) complicated by autoimmune hemolytic anemia. A series of nine such patients who underwent this procedure at our institution between August 1997 and September 2001 were retrospectively reviewed. Seven of 9 patients who underwent laparoscopic splenectomy for CLL and autoimmune hemolytic anemia achieved a complete response. One patient who initially responded relapsed 12 weeks postoperatively. Therefore, six of 9 patients showed sustained responses with a mean follow-up of 2 years, consistent with other published series. Two patients had no response, one of whom died within 3 weeks of surgery from transformed Hodgkin's disease. The only other postoperative complication occurred in a patient who developed pneumonia. We conclude that laparoscopic splenectomy is a safe and effective treatment for autoimmune hemolytic anemia in patients with CLL who fail medical therapy.
|
Authors | John Hill, R Matthew Walsh, Scott McHam, Fred Brody, Matt Kalaycio |
Journal | American journal of hematology
(Am J Hematol)
Vol. 75
Issue 3
Pg. 134-8
(Mar 2004)
ISSN: 0361-8609 [Print] United States |
PMID | 14978692
(Publication Type: Journal Article, Review)
|
Copyright | Copyright 2004 Wiley-Liss, Inc. |
Topics |
- Aged
- Anemia, Hemolytic, Autoimmune
(blood, complications, surgery)
- Case-Control Studies
- Female
- Follow-Up Studies
- Humans
- Laparoscopy
(adverse effects, methods, mortality)
- Leukemia, Lymphocytic, Chronic, B-Cell
(blood, complications)
- Male
- Middle Aged
- Recurrence
- Retrospective Studies
- Splenectomy
(adverse effects, methods, mortality)
- Treatment Outcome
|